Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat

Phytomedicine

Volumn 14, Issue 10, 2007, Pages 681-689

  Banz, William J ^a,b   Iqbal, M J ^a   Bollaert, Michael ^a   Chickris, Nicole ^a   James, Bryce ^a   Higginbotham, D Allan ^a,b   Peterson, Richard ^c   Murphy, Laura ^b  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Ginseng; Insulin resistance; Obesity; Peroxisome proliferator activated receptor (PPAR); Zucker Diabetic Fatty (ZDF) rat

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN D; CHOLESTEROL; FATTY ACID; GINSENG EXTRACT; GLUCOSE; HORMONE SENSITIVE LIPASE; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN RECEPTOR; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DNA SYNTHESIS; FATTY ACID SYNTHESIS; FOOD INTAKE; GENE EXPRESSION; GINSENG; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY MASS; MALE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ZUCKER DIABETIC FATTY RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS; DIET; DNA PRIMERS; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; MALE; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; PPAR GAMMA; RATS; RATS, ZUCKER; THIAZOLIDINEDIONES; TRIGLYCERIDES;

ANIMALIA; PANAX GINSENG; PANAX QUINQUEFOLIUS; RATTUS;

EID: 34548684318     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.06.003     Document Type: Article

References (51)

1. Attele A.S., Zhou Y.P., Xie J.T., Wu J.A., Zhang L., Dey L., Pugh W., Rue P.A., Polonsky K.S., and Yuan C.S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51 (2002) 1851-1858
2. Banz W.J., Davis J., Steinle J.J., Adler S., Oitker J., Winters T.A., Higginbotham D.A., Hou Y., Henry N., Peterson R., and Meyers C.Y. ((+)-Z-Bisdehydrodoisynolic acid ameliorates obesity and the metabolic syndrome in female ZDF rats. Obes. Res. 13 (2005) 1915-1924
3. Banz W.J., Bollaert M., Iqbal M.J., Higginbotham D.A., Peterson R., and Murphy L.L. Ginseng modifies the diabetic phenotype and genes associated with diabetes in male ZDF rat. FASEB J. 20 (2006) A1017
4. Bao T.T. Effect of total saponin of Panax ginseng on alloxan diabetes in mice. Yao Xue Xue Bao 16 (1981) 618-620
5. Blumenthal M. Asian ginseng: potential therapeutic uses. Adv. Nurse Pract. 9 (2001) 26-28, 33
6. Bookout A.L., and Mangelsdorf D.J. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal 1 (2003) e012
7. Chung S.H., Choi C.G., and Park S.H. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch. Pharm. Res. 24 (2001) 214-218
8. Cicero A.F., Vitale G., Savino G., and Arletti R. Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother. Res. 17 (2003) 174-178
9. Coleman C.I., Hebert J.H., and Reddy P. The effects of Panax ginseng on quality of life. J. Clin. Pharm. Ther. 28 (2003) 5-15
10. Corbit R.M., Ferreira J.F., Ebbs S.D., and Murphy L.L. Simplified extraction of ginsenosides from American ginseng (Panax quinquefolius L.) for high-performance liquid chromatography-ultraviolet analysis. J. Agric. Food Chem. 53 (2005) 9867-9873
11. Cuddy M.L. Commonly used herbs. J. Pract. Nurs. 53 (2003) 5-9
12. Davis J., Iqbal M.J., Steinle J., Oitker J., Higginbotham D.A., Peterson R.G., and Banz W.J. Soy protein influences the development of the metabolic syndrome in male obese ZDF×SHHF rats. Horm. Metab. Res. 37 (2005) 316-325
13. Davis J., Steinle J., Higginbotham D.A., Oitker J., Peterson R.G., and Banz W.J. Soy protein influences insulin sensitivity and cardiovascular risk in male lean SHHF rats. Horm. Metab. Res. 37 (2005) 309-315
14. Davis J., Higginbotham A., O'connor T., Moustaid-Moussa N., Tebbe A., Kim Y.C., Cho K.W., Shay N., Adler S., Peterson R., and Banz W. Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat. Ann. Nutr. Metab. 51 (2007) 42-52
15. Dey L., Zhang L., and Yuan C.S. Anti-diabetic and anti-obese effects of ginseng berry extract: comparison between intraperitoneal and oral administrations. Am. J. Chin. Med. 30 (2002) 645-647
16. Dey L., Xie J.T., Wang A., Wu J., Maleckar S.A., and Yuan C.S. Anti-hyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine 10 (2003) 600-605
17. Han K.L., Jung M.H., Sohn J.H., and Hwang J.K. Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes. Biol. Pharm. Bull. 29 (2006) 110-113
18. Han K.L., Jung M.H., Sohn J.H., and Hwang J.K. Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes. Biol. Pharm. Bull. 29 (2006) 110-113
19. Huntley A.L., and Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 10 (2003) 465-476
20. Jung C.H., Seog H.M., Choi I.W., Choi H.D., and Cho H.Y. Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats. J. Ethnopharmacol. 98 (2005) 245-250
21. Kang K.S., Kim H.Y., Yamabe N., Nagai R., and Yokozawa T. Protective effect of sun ginseng against diabetic renal damage. Biol. Pharm. Bull. 29 (2006) 1678-1684
22. Kim S.H., and Park K.S. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol. Res. 48 (2003) 511-513
23. Kim J.H., Hahm D.H., Yang D.C., Kim J.H., Lee H.J., and Shim I. Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. J. Pharmacol. Sci. 97 (2005) 124-131
24. Kimura M., and Suzuki J. The pattern of action of blended Chinese traditional medicines to glucose tolerance curves in genetically diabetic KK-CAy mice. J. Pharmacobiodyn. 4 (1981) 907-915
25. Kimura M., Waki I., Chujo T., Kikuchi T., Hiyama C., Yamazaki K., and Tanaka O. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J. Pharmacobiodyn. 4 (1981) 410-417
26. Kimura M., Waki I., Tanaka O., Nagai Y., and Shibata S. Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J. Pharmacobiodyn. 4 (1981) 402-409
27. Kintscher U., and Law R.E. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E287-E291
28. Lee H., Gonzalez F.J., and Yoon M. Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha. Biochem. Biophys. Res. Commun. 339 (2006) 196-203
29. Li A.C., and Glass C.K. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J. Lipid Res. 45 (2004) 2161-2173
30. Li X., Hansen P.A., Xi L., Chandraratna R.A.S., and Burant C.F. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor {gamma} and retinoic acid×receptors. J. Biol. Chem. 280 (2005) 38317-38327
31. McCabe S. Complementary herbal and alternative drugs in clinical practice. Perspect. Psychiatr. Care 38 (2002) 98-107
32. Michalik L., Auwerx J., Berger J.P., Chatterjee V.K., Glass C.K., Gonzalez F.J., Grimaldi P.A., Kadowaki T., Lazar M.A., O'Rahilly S., Palmer C.N., Plutzky J., Reddy J.K., Spiegelman B.M., Staels B., and Wahli W. International union of pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 58 (2006) 726-741
33. Park M.Y., Lee K.S., and Sung M.K. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-alpha, PPAR-gamma, and LPL mRNA expressions. Life Sci. (2005)
34. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993) 1939-1951
35. Shan J., Deng J.E., Tian G., and Zhao C. Preliminary study on hypoglycemic activities of natural polysaccharides and their mechanism. Zhong Yao Cai 25 (2002) 139-143
36. Shang W., Yang Y., Jiang B., Jin H., Zhou L., Liu S., and Chen M. Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression. Life Sci. 80 (2007) 618-625
37. Sotaniemi E.A., Haapakoski E., and Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 18 (1995) 1373-1375
38. Tesch B.J. Herbs commonly used by women: an evidence-based review. Am. J. Obstet. Gynecol. 188 (2003) S44-S55
39. Vuksan V., Sievenpiper J.L., Wong J., Xu Z., Beljan-Zdravkovic U., Arnason J.T., Assinewe V., Stavro M.P., Jenkins A.L., Leiter L.A., and Francis T. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. Am. J. Clin. Nutr. 73 (2001) 753-758
40. Vuksan V., Sievenpiper J.L., Koo V.Y., Francis T., Beljan-Zdravkovic U., Xu Z., and Vidgen E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch. Intern. Med. 160 (2000) 1009-1013
41. Vuksan V., Stavro M.P., Sievenpiper J.L., Beljan-Zdravkovic U., Leiter L.A., Josse R.G., and Xu Z. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23 (2000) 1221-1226
42. Vuksan V., Sung M.K., Sievenpiper J.L., Stavro P.M., Jenkins A.L., Di Buono M., Lee K.S., Leiter L.A., Nam K.Y., Arnason J.T., Choi M., and Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr. Metab. Cardiovasc. Dis. (2006)
43. Wang L., Higashiura K., Ura N., Miura T., and Shimamoto K. Chinese medicine, Jiang-Tang-Ke-Li, improves insulin resistance by modulating muscle fiber composition and muscle tumor necrosis factor-alpha in fructose-fed rats. Hypertens. Res. 26 (2003) 527-532
44. Xie J.T., Aung H.H., Wu J.A., Attel A.S., and Yuan C.S. Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am. J. Chin. Med. 30 (2002) 187-194
45. Xie J.T., Zhou Y.P., Dey L., Attele A.S., Wu J.A., Gu M., Polonsky K.S., and Yuan C.S. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 9 (2002) 254-258
46. Xie J.T., Mehendale S.R., Wang A., Han A.H., Wu J.A., Osinski J., and Yuan C.S. American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol. Res. 49 (2004) 113-117
47. Xie J.T., Wu J.A., Mehendale S., Aung H.H., and Yuan C.S. Anti-hyperglycemic effect of the polysaccharides fraction from American ginseng berry extract in ob/ob mice. Phytomedicine 11 (2004) 182-187
48. Xie J.T., Wang C.Z., Wang A.B., Wu J., Basila D., and Yuan C.S. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta. Pharmacol. Sin. 26 (2005) 1104-1110
49. Yokozawa T., and Liu Z.W. The role of ginsenoside-Rd in cisplatin-induced acute renal failure. Ren. Fail 22 (2000) 115-127
50. Yoon M., Lee H., Jeong S., Kim J.J., Nicol C.J., Nam K.W., Kim M., Cho B.G., and Oh G.T. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng. Br. J. Pharmacol. 138 (2003) 1295-1302
51. Yun S.N., Moon S.J., Ko S.K., Im B.O., and Chung S.H. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch. Pharm. Res. 27 (2004) 790-796